Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kenji Kunieda
Observed names:
K Kunieda,
K. Kunieda
Institutions:
Saku Central Hospital,
Saku Central Hospital Advanced Care Center
Observed institutions:
Shizuoka Cancer Center,
Saku Central Hospital,
Saku Central Hospital Advanced Care Center
OpenAlex ID:
A5110198101
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
2018
·
Ken Kato
, Taroh Satoh
, et al.
·
Gastric Cancer
·
73
PDF
Antimicrobial stewardship without infectious disease physician for patients with candidemia: A before and after study
2018
·
Minoru Murakami
, Hirokazu Komatsu
, et al.
·
Journal of General and Family Medicine
·
28
PDF
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study
2018
·
Akitaka Makiyama
, Kenji Kunieda
, et al.
·
Gastric Cancer
·
17
PDF
Phase II study of S-1 plus oxaliplatin 130 mg/m2 in Japanese patients with advanced gastric cancer
2018
·
Yosuke Kito
, Nozomu Machida
, et al.
·
International Journal of Clinical Oncology
·
11
Granulocytic sarcoma of the jejunum diagnosed by biopsies during double‐balloon endoscopy before treatment (with video)
2013
·
Kinichi Hotta
, Kenji Kunieda
·
Digestive Endoscopy
·
7
Risk of colonoscopic post-polypectomy bleeding in patients after the discontinuation of antithrombotic therapy
2020
·
Takaaki Kishino
, Tsuneo Oyama
, et al.
·
The Turkish Journal of Gastroenterology
·
6
PDF
Granulocytic sarcoma of the ileum observed by double-balloon endoscopy before treatment (with video)
2013
·
Kinichi Hotta
, Kenji Kunieda
·
Gastrointestinal Endoscopy
·
3
Neuroprotective effects of goshajinkigan (TJ-107) in colorectal cancer patients receiving oxaliplatin-based chemotherapy: A double-blind, placebo-controlled, randomized phase II trial from the GONE Study Group.
2011
·
T. Matsui
, T. Kono
, et al.
·
Journal of Clinical Oncology
·
3
[Locoregional therapy for liver metastases of colorectal cancer].
1996
·
Y Sugiyama
, S Saji
, et al.
·
PubMed
·
3
Phase I Clinical Trial of Ds-7423, an Oral Pi3K/Mtor Dual Inhibitor, in Japanese Patients with Advanced Solid Tumors
2014
·
T. Yokota
, T. Tsushima
, et al.
·
Annals of Oncology
·
2
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial ( HYBRID )
2024
·
Hiroyuki Arai
, Takashi Tsuda
, et al.
·
Cancer Medicine
·
1
PDF
Phase II study of S-1 plus oxaliplatin (OX) at dose of 130 mg/m2 (SOX130) in Japanese patients (pts) with advanced gastric cancer (AGC).
2017
·
Yosuke Kito
, Nozomu Machida
, et al.
·
Journal of Clinical Oncology
·
1
Bevacizumab Plus Paclitaxel for Her2 Negative Advanced/Recurrent Breast Cancer: Assessment of Efficacy and Safety
2014
·
Kenji Kunieda
, Satomi Matsuo
, et al.
·
Annals of Oncology
·
1
PDF
[Clinical evaluation of intermittent hepatic arterial infusion therapy for metastatic liver tumor of gastric and colorectal cancer].
1998
·
K Miya
, T Adachi
, et al.
·
PubMed
·
1
[A new modality of locoregional chemotherapy based on biochemical double modulation of 5-fluorouracil with both leucovorin and cisplatin against liver metastases of colorectal cancer].
1995
·
Y Sugiyama
, S Saji
, et al.
·
PubMed
·
1
Early Stage Type 0-IIa Gastric Cancer
2016
·
Kenji Kunieda
·
Springer eBooks
Multicenter retrospective analysis for elderly patients with advanced gastric cancer (AGC) received first-line chemotherapy in clinical practice.
2015
·
Kenji Kunieda
, Akitaka Makiyama
, et al.
·
Journal of Clinical Oncology
Efficacy and Safety of Gemcitabine as First-Line Therapy in Patients Aged 65 and Older with Advanced Pancreatic Cancer
2014
·
Yosuke Kito
, Akiko Todaka
, et al.
·
Annals of Oncology
PDF
[Immunochemotherapy for cancer patients of the stomach--cancer therapy keeping with good host-immunocompetency].
2001
·
S Saji
, K Kunieda
, et al.
·
PubMed
[Clinical evaluation of intermittent hepatic arterial infusion therapy with CDDP and 5-FU for liver metastasis of colorectal cancer].
1999
·
K Miya
, S Saji
, et al.
·
PubMed
Characteristics of immunity in advanced gastrointestinal cancer patients and countermeasures against its postoperative decline
1999
·
M. Kato
, S Saji
, et al.
Show more works
View as search
Works count:
21
Citation count:
158
H-index:
6
I10-index:
4
Year
Topic
Type